Tag: LEQEMBI
Soleo Health scales to meet demand for approved Alzheimer’s drug
July 10, 2023HME News Staff
FRISCO, Texas – Soleo Health says it’s prepared to address anticipated increases in demand for LEQEMBI on the heels of the U.S. Food and Drug Administration giving the Alzheimer’s drug full approval on July 7. Earlier this year, Soleo Health was selected by Eisai as the specialty pharmacy distribution partner for LEQEMBI. At the time, the drug had only received fast-track approval from the FDA. “LEQEMBI represents an important advancement in the ongoing fight to treat Alzheimer’s...
Soleo Health to distribute new Alzheimer’s treatment
January 11, 2023HME News Staff
FRISCO, Texas – Soleo Health, a national provider of complex specialty pharmacy services, has been selected by Eisai Inc., a developer of pharmaceuticals, as the sole specialty pharmacy distribution partner for LEQEMBI, which was recently approved by the U.S. Food & Drug Administration for the treatment of Alzheimer’s disease. LEQEMBI is an anti-amyloid monoclonal antibody used to treat mild cognitive impairment due to Alzheimer’s and mild or early Alzheimer’s disease (collectively...